These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 39162797)

  • 1. ETS1 deficiency in macrophages suppresses colorectal cancer progression by reducing the F4/80+TIM4+ macrophage population.
    Cao Y; Guo A; Li M; Ma X; Bian X; Chen Y; Zhang C; Huang S; Zhao W; Zhao S
    Carcinogenesis; 2024 Oct; 45(10):745-758. PubMed ID: 39162797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crosstalk between cancer cells and tumor associated macrophages is required for mesenchymal circulating tumor cell-mediated colorectal cancer metastasis.
    Wei C; Yang C; Wang S; Shi D; Zhang C; Lin X; Liu Q; Dou R; Xiong B
    Mol Cancer; 2019 Mar; 18(1):64. PubMed ID: 30927925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HMGA2 facilitates colorectal cancer progression via STAT3-mediated tumor-associated macrophage recruitment.
    Wang X; Wang J; Zhao J; Wang H; Chen J; Wu J
    Theranostics; 2022; 12(2):963-975. PubMed ID: 34976223
    [No Abstract]   [Full Text] [Related]  

  • 4. PIM1/NF-κB/CCL2 blockade enhances anti-PD-1 therapy response by modulating macrophage infiltration and polarization in tumor microenvironment of NSCLC.
    Chen X; Zhou J; Wang Y; Wang X; Chen K; Chen Q; Huang D; Jiang R
    Oncogene; 2024 Aug; 43(33):2517-2530. PubMed ID: 39004633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CPEB3 inhibits epithelial-mesenchymal transition by disrupting the crosstalk between colorectal cancer cells and tumor-associated macrophages via IL-6R/STAT3 signaling.
    Zhong Q; Fang Y; Lai Q; Wang S; He C; Li A; Liu S; Yan Q
    J Exp Clin Cancer Res; 2020 Jul; 39(1):132. PubMed ID: 32653013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor cell-derived SPON2 promotes M2-polarized tumor-associated macrophage infiltration and cancer progression by activating PYK2 in CRC.
    Huang C; Ou R; Chen X; Zhang Y; Li J; Liang Y; Zhu X; Liu L; Li M; Lin D; Qiu J; Liu G; Zhang L; Wu Y; Tang H; Liu Y; Liang L; Ding Y; Liao W
    J Exp Clin Cancer Res; 2021 Sep; 40(1):304. PubMed ID: 34583750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The active fraction of Garcinia yunnanensis suppresses the progression of colorectal carcinoma by interfering with tumorassociated macrophage-associated M2 macrophage polarization in vivo and in vitro.
    Sui H; Tan H; Fu J; Song Q; Jia R; Han L; Lv Y; Zhang H; Zheng D; Dong L; Wang S; Li Q; Xu H
    FASEB J; 2020 Jun; 34(6):7387-7403. PubMed ID: 32283574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NT5DC2 knockdown inhibits colorectal carcinoma progression by repressing metastasis, angiogenesis and tumor-associated macrophage recruitment: A mechanism involving VEGF signaling.
    Zhu Z; Hou Q; Guo H
    Exp Cell Res; 2020 Dec; 397(1):112311. PubMed ID: 32991874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ETS1-mediated Regulation of SOAT1 Enhances the Malignant Phenotype of Oral Squamous Cell Carcinoma and Induces Tumor-associated Macrophages M2-like Polarization.
    Liu Y; Shen L; Li Y; Sun X; Liang L; Jiang S; Zhang Z; Tang X; Tao Y; Xie L; Jiang Y; Cong L
    Int J Biol Sci; 2024; 20(9):3372-3392. PubMed ID: 38993570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wnt5a-induced M2 polarization of tumor-associated macrophages via IL-10 promotes colorectal cancer progression.
    Liu Q; Yang C; Wang S; Shi D; Wei C; Song J; Lin X; Dou R; Bai J; Xiang Z; Huang S; Liu K; Xiong B
    Cell Commun Signal; 2020 Mar; 18(1):51. PubMed ID: 32228612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Ap-2α/Elk-1 axis regulates Sirpα-dependent tumor phagocytosis by tumor-associated macrophages in colorectal cancer.
    Wang X; Luo X; Chen C; Tang Y; Li L; Mo B; Liang H; Yu S
    Signal Transduct Target Ther; 2020 Apr; 5(1):35. PubMed ID: 32296015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD133-containing microvesicles promote cancer progression by inducing M2-like tumor-associated macrophage polarization in the tumor microenvironment of colorectal cancer.
    Kim SY; Park S; Kim S; Ko J
    Carcinogenesis; 2024 May; 45(5):300-310. PubMed ID: 38085813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cetuximab enhances the anti-tumor function of macrophages in an IL-6 dependent manner.
    Zhao Y; Liu X; Huo M; Wang Y; Li Y; Xu N; Zhu H
    Life Sci; 2021 Feb; 267():118953. PubMed ID: 33359746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Total glucosides of paeony inhibit breast cancer growth by inhibiting TAMs infiltration through NF-κB/CCL2 signaling.
    Jin L; Guo Y; Mao W; Wang J; Jin L; Liu X; Shou Q; Fu H
    Phytomedicine; 2022 Sep; 104():154307. PubMed ID: 35841664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CXCL12-mediated HOXB5 overexpression facilitates Colorectal Cancer metastasis through transactivating CXCR4 and ITGB3.
    Feng W; Huang W; Chen J; Qiao C; Liu D; Ji X; Xie M; Zhang T; Wang Y; Sun M; Tian D; Fan D; Nie Y; Wu K; Xia L
    Theranostics; 2021; 11(6):2612-2633. PubMed ID: 33456563
    [No Abstract]   [Full Text] [Related]  

  • 16. Hsa_circ_0009092/miR-665/NLK signaling axis suppresses colorectal cancer progression via recruiting TAMs in the tumor microenvironment.
    Song J; Liu Q; Han L; Song T; Huang S; Zhang X; He Q; Liang C; Zhu S; Xiong B
    J Exp Clin Cancer Res; 2023 Nov; 42(1):319. PubMed ID: 38008713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wnt5a/CaMKII/ERK/CCL2 axis is required for tumor-associated macrophages to promote colorectal cancer progression.
    Liu Q; Song J; Pan Y; Shi D; Yang C; Wang S; Xiong B
    Int J Biol Sci; 2020; 16(6):1023-1034. PubMed ID: 32140070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TCF4 enhances hepatic metastasis of colorectal cancer by regulating tumor-associated macrophage via CCL2/CCR2 signaling.
    Tu W; Gong J; Zhou Z; Tian D; Wang Z
    Cell Death Dis; 2021 Sep; 12(10):882. PubMed ID: 34580284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pexidartinib and Immune Checkpoint Inhibitors Combine to Activate Tumor Immunity in a Murine Colorectal Cancer Model by Depleting M2 Macrophages Differentiated by Cancer-Associated Fibroblasts.
    Shimizu D; Yuge R; Kitadai Y; Ariyoshi M; Miyamoto R; Hiyama Y; Takigawa H; Urabe Y; Oka S
    Int J Mol Sci; 2024 Jun; 25(13):. PubMed ID: 39000110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CTHRC1 promotes colorectal cancer progression by recruiting tumor-associated macrophages via up-regulation of CCL15.
    Liu Y; Chen X; Xu Y; Yang T; Wang H; Wang Z; Hu Z; Chen L; Zhang Z; Wu Y
    J Mol Med (Berl); 2024 Jan; 102(1):81-94. PubMed ID: 37987774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.